The brain is one of the body’s most energy-demanding organs, accounting for 2 percent of the body’s weight but consuming 20 ...

First-ever clinical trial exclusively conducted among people with hard-to-treat form of tuberculosis known as pre-extensively drug-resistant TB shows many patients benefit from shorter, simpler ...

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...

Our educational programs advance Harvard Medical School's core mission to alleviate human suffering by nurturing a diverse group of leaders and future leaders in both clinical care and biomedical ...

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer… ...

A new study from investigators at the Benson-Henry Institute for Mind/Body Medicine at Massachusetts General Hospital and Beth Israel Deaconess Medical Center finds that eliciting the relaxation ...

Center for the Integration of Medicine and Innovative Technology (CIMIT) ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long endeavor reached fruition in the form of a new treatment, CASGEVY, approved by ...

A Mammoth Solution Scientists look to extinct genes to protect endangered species, climate ...

For Rogulja, an associate professor of neurobiology in the Blavatnik Institute at Harvard Medical School, an intriguing aspect of sleep is the loss of consciousness and awareness it brings, as the ...

What causes long COVID? More than three years after the start of the pandemic, this remains the most bedeviling question about a mystifying syndrome estimated to affect some 65 million people globally ...

At a glance: Study shows AI improves performance for some radiologists but worsens it for others. Understanding who might benefit from AI and who would not is critical for designing tools that boost ...